Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

867 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
Verheugt FW, Granger CB. Verheugt FW, et al. Among authors: granger cb. Lancet. 2015 Jul 18;386(9990):303-10. doi: 10.1016/S0140-6736(15)60245-8. Epub 2015 Mar 14. Lancet. 2015. PMID: 25777666 Review.
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
Newby LK, Califf RM, White HD, Harrington RA, Van de Werf F, Granger CB, Simes RJ, Hasselblad V, Armstrong PW. Newby LK, et al. Among authors: granger cb. Am J Med. 2002 Jun 1;112(8):647-58. doi: 10.1016/s0002-9343(02)01106-3. Am J Med. 2002. PMID: 12034415
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Granger CB, et al. Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5. Lancet. 2003. PMID: 13678870 Clinical Trial.
Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
Waters RE 2nd, Mahaffey KW, Granger CB, Roe MT. Waters RE 2nd, et al. Among authors: granger cb. Am Heart J. 2003 Dec;146(6):958-68. doi: 10.1016/S0002-8703(03)00439-3. Am Heart J. 2003. PMID: 14660986
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report.
Granger CB, Van Eyk JE, Mockrin SC, Anderson NL; National Heart, Lung, And Blood Institute Clinical Proteomics Working Group. Granger CB, et al. Circulation. 2004 Apr 13;109(14):1697-703. doi: 10.1161/01.CIR.0000121563.47232.2A. Circulation. 2004. PMID: 15078805
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.
Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA; CHARM investigators. Granger BB, et al. Among authors: granger cb. Lancet. 2005 Dec 10;366(9502):2005-11. doi: 10.1016/S0140-6736(05)67760-4. Lancet. 2005. PMID: 16338449 Clinical Trial.
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.
Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, Van de Werf F, White H, Califf RM, Harrington RA. Patel MR, et al. Among authors: granger cb. Am Heart J. 2006 Feb;151(2):316-22. doi: 10.1016/j.ahj.2005.04.014. Am Heart J. 2006. PMID: 16442893
Bleeding in acute coronary syndromes.
Granger CB. Granger CB. Timely Top Med Cardiovasc Dis. 2006 Nov 1;10:E30. Timely Top Med Cardiovasc Dis. 2006. PMID: 17136236 No abstract available.
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes.
Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Rao SV, et al. Among authors: granger cb. Eur Heart J. 2007 May;28(10):1193-204. doi: 10.1093/eurheartj/ehm019. Epub 2007 Apr 24. Eur Heart J. 2007. PMID: 17456480 Review.
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED. Berger JS, et al. Among authors: granger cb. Circulation. 2008 Jan 15;117(2):192-9. doi: 10.1161/CIRCULATIONAHA.107.729558. Epub 2007 Dec 17. Circulation. 2008. PMID: 18086929 Clinical Trial.
867 results
Jump to page
Feedback